hepatoxicity | Visikol

The Power of HUREL® Micro Livers in Predicting Drug Toxicity

Carol Tomaszewski2024-08-19T14:10:53-05:00Tags: cytotoxicity, Drug Toxicity, hepatoxicity, HUREL Micro Liver Services, Liver Toxicity|

Drug toxicity is a major concern in the pharmaceutical industry. It is essential to identify potential toxic effects of [...]

Hepatoxicity Screening Webinar On Demand

Carol Tomaszewski2023-02-02T08:34:46-05:00Tags: Agilent, hepatoxicity, HUREL|

Watch the 'Hepatotoxicity Screening in HUREL® Micro Liver Models with Agilent xCELLigence Real-Time Cell Analyzer' webinar on demand now! Watch Here Summary The [...]

HUREL Models Assist in the Evaluation of Hepatoxicity

Carol Tomaszewski2021-10-25T09:07:40-05:00Tags: DILI, drug discovery, hepatoxicity, HUREL, Micro Livers|

Many drug candidates fail during clinical trials and post-market withdrawal due to hepatoxicity or Drug Induced Liver Injury (DILI). [...]